TICAM Antibodies

Santa Cruz Biotechnology features a diverse variety of TICAM Antibodies for advanced research in immunology and cell signaling. TICAM Antibodies are validated for multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TICAM, also known as TRIF, plays a crucial role in the innate immune response by mediating signaling pathways activated by Toll-like receptors (TLRs). TICAM is essential for the production of pro-inflammatory cytokines and the activation of adaptive immunity, making it a key player in the body's defense against pathogens. Understanding TICAM function is vital for developing therapeutic strategies against various diseases, including infections and autoimmune disorders. TICAM research has revealed significant insights into immune system regulation and cellular defense mechanisms. Ongoing studies continue to uncover new aspects of TICAM's role in immune response pathways. Current investigations focus on how TICAM influences various cellular processes and immune system responses. Santa Cruz Biotechnology monoclonal antibodies for TICAM support researchers worldwide in advancing our understanding of immune system function and disease treatment.